𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of the anti-tumour necrosis factor monoclonal antibody—infliximab—to treat ulcerative colitis: implications and trends beyond the available data

✍ Scribed by S. Rossetti; G.C. Actis; M. Fadda; M. Rizzetto; A. Palmo


Book ID
119227725
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
60 KB
Volume
36
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.